• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body.

作者信息

Chiou W L, Lam G, Chen M L, Lee M G

出版信息

Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):17-26.

PMID:7058288
Abstract

Using dogs or rabbits as model animals the effect of arterial-venous plasma concentration differences of propranolol, procainamide, griseofulvin, furosemide and theophylline on the determination of mean residence time (MRT) following intravenous administration was evaluated using standard methods. The MRT values calculated from femoral venous data were always higher (ranging from 1.5 to 109%) than those from femoral arterial data. The differences were mainly attributed to the additional residence time of drugs in the sampling tissue (leg). From a physiological point of view it appears generally more logical to assume that only the MRT calculated from arterial data using conventional methods represents the "true" MRT in the body. The potential pharmacokinetic significance of the present findings is discussed. New approaches, which eliminates the effect of arterial-venous plasma concentration differences on the MRT determination, are proposed.

摘要

相似文献

1
Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body.
Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):17-26.
2
Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.
Res Commun Chem Pathol Pharmacol. 1981 Apr;32(1):27-39.
3
Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
Res Commun Chem Pathol Pharmacol. 1981 Jul;33(1):33-48.
4
Arterial and venous blood sampling in pharmacokinetic studies: bumetanide in rabbits.药代动力学研究中的动静脉采血:家兔中的布美他尼
Res Commun Mol Pathol Pharmacol. 1997 Dec;98(3):255-64.
5
Instantaneous input hypothesis in pharmacokinetic studies.
J Pharm Sci. 1981 Sep;70(9):1037-9. doi: 10.1002/jps.2600700918.
6
The significance of the arterial-venous plasma concentration difference in clearance studies.动静脉血浆浓度差在清除率研究中的意义。
Int J Clin Pharmacol Ther Toxicol. 1982 May;20(5):197-203.
7
The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.样本合并方法在药代动力学研究中用于确定曲线下面积(AUC)、一阶矩曲线下面积(AUMC)和平均驻留时间的应用。
Fundam Clin Pharmacol. 2005 Jun;19(3):347-54. doi: 10.1111/j.1472-8206.2005.00329.x.
8
Arterial and venous blood sampling in pharmacokinetic studies: griseofulvin.
J Pharm Sci. 1982 Dec;71(12):1386-9. doi: 10.1002/jps.2600711219.
9
The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).药物浓度对采血部位显著依赖的现象及原理。在药代动力学、药效学、毒理学和治疗学中的意义(第一部分)
Clin Pharmacokinet. 1989 Sep;17(3):175-99. doi: 10.2165/00003088-198917030-00004.
10
The physiological significance of the apparent volume of distribution, Vdarea or Vd beta, in pharmacokinetic studies.
Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):499-508.

引用本文的文献

1
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.静脉注射后甲氨蝶呤和7-羟基甲氨蝶呤在兔体内的药代动力学
J Pharmacokinet Biopharm. 1983 Oct;11(5):499-513. doi: 10.1007/BF01062208.
2
Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
J Pharmacokinet Biopharm. 1984 Dec;12(6):597-610. doi: 10.1007/BF01059555.
3
Definition of pharmacokinetic parameters: influence of the sampling site.
J Pharmacokinet Biopharm. 1984 Apr;12(2):167-75. doi: 10.1007/BF01059276.
4
Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.补液速率和成分对静脉注射呋塞米的药代动力学和药效学的影响。
J Pharmacokinet Biopharm. 1986 Oct;14(5):495-509. doi: 10.1007/BF01059657.
5
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).药代动力学中的平均时间参数。定义、计算及临床意义(第二部分)
Clin Pharmacokinet. 1989 Dec;17(6):424-40. doi: 10.2165/00003088-198917060-00005.
6
The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).药物浓度对采血部位显著依赖的现象及原理。在药代动力学、药效学、毒理学及治疗学中的意义(第二部分)
Clin Pharmacokinet. 1989 Oct;17(4):275-90. doi: 10.2165/00003088-198917040-00005.
7
Analysis of arterial-venous blood concentration difference of drugs based on recirculatory theory with fast inverse Laplace transform (FILT).基于快速拉普拉斯逆变换(FILT)循环理论的药物动静脉血药浓度差分析。
J Pharmacokinet Biopharm. 1991 Feb;19(1):71-85. doi: 10.1007/BF01062193.
8
Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.给予普萘洛尔和茶碱后小鼠新皮质切片中神经递质敏感性的变化。
Br J Pharmacol. 1991 Mar;102(3):711-7. doi: 10.1111/j.1476-5381.1991.tb12238.x.